Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By boosting these receptors, https://fayolol115584.activablog.com/35365668/tirzepatide-a-promising-new-treatment-for-obesity